炎症,自身免疫和神经退行性疾病,治疗和超越
Jenny Valentina Garmendia1, Claudia Valentina De Sanctis1, Viswanath Das1,2
1Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, The Czech Republic.
Current neuropharmacology
|October 29, 2023
概括
炎症加速神经退行性疾病,如阿尔茨海默氏症和帕金森病. 基于免疫的疗法,包括疫苗和抗体治疗,有望减缓疾病的进展.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 神经退行性疾病 (NDs),包括阿尔茨海默氏症 (AD) 和帕金森病 (PD),由于预期寿命的延长,越来越普遍.
- 这些复杂的疾病受到遗传和环境因素的影响,炎症成为发病和进展的关键加速器.
- 患有自身免疫性疾病的患者可能面临AD和PD的风险增加,尽管适当的治疗可以减轻这种风险.
- 在AD和PD患者中,针对关键病理蛋白质 (tau,β-粉样蛋白,α-synuclein) 的自身抗体的存在表明潜在的保护性免疫作用.
研究的目的:
- 审查炎症对神经退行性疾病进展的影响.
- 探索针对阿尔茨海默氏症和帕金森病的基于免疫的治疗策略的潜力.
- 检查神经退行性疾病管理中的新兴治疗方法和未来前景.
主要方法:
- 关于最近关于炎症和神经退行症的研究的文献综述.
- 对免疫系统参与阿尔茨海默氏症和帕金森病的分析.
- 评估拟议的基于免疫的疗法,包括单克隆抗体和疫苗.
- 检查细胞因子调节策略 (抑制和添加).
主要成果:
- 局部和全身的炎症显著促进了神经退行性疾病发病和进展的加速.
- 针对异常的,β-粉样蛋白和α-synuclein的自身抗体可能在AD和PD中具有保护功能.
- 目前正在研究各种基于免疫的治疗策略,显示出疾病修饰的潜力.
结论:
- 基于免疫的疗法,利用对自身抗体功能和炎症调节的洞察力,代表了治疗阿尔茨海默氏症和帕金森病的前沿.
- 对细胞因子抑制,抗体治疗和疫苗接种策略的进一步研究对于开发有效干预措施至关重要.
- 考虑到ND和个体免疫反应的异质性质的个性化方法将是未来治疗成功的关键.
相关概念视频
Autoimmune Disorders
456
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
456
Inflammatory Response
2.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Inflammation
53.7K
Overview
53.7K
Disorders of the Nervous Tissue
1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567


